| Product Code: ETC9950019 | Publication Date: Sep 2024 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the United Kingdom import trend for non-steroidal anti-inflammatory drugs saw a growth rate of 0.67%, with a compound annual growth rate (CAGR) of 2.33% from 2020 to 2024. This modest growth can be attributed to stable demand and ongoing market stability within the UK pharmaceutical sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, 2022 & 2032F |
3.3 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market - Industry Life Cycle |
3.4 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market - Porter's Five Forces |
3.5 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.6 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Disease Indication, 2022 & 2032F |
3.7 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in the aging population in the UK leading to higher prevalence of musculoskeletal disorders and arthritis, driving the demand for non-steroidal anti-inflammatory drugs (NSAIDs). |
4.2.2 Rising awareness among the population about the benefits of NSAIDs in managing pain and inflammation. |
4.2.3 Growing trend towards self-medication and over-the-counter availability of NSAIDs, boosting market accessibility. |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines surrounding the use of NSAIDs due to potential side effects and risks. |
4.3.2 Competition from alternative pain management therapies such as physical therapy, acupuncture, and natural remedies. |
5 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Trends |
6 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market, By Types |
6.1 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Route of Administration, 2022-2032F |
6.1.3 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Oral, 2022-2032F |
6.1.4 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Parenteral, 2022-2032F |
6.1.5 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Topical, 2022-2032F |
6.2 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Arthritis, 2022-2032F |
6.2.3 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Migraine, 2022-2032F |
6.2.4 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Ophthalmic Diseases, 2022-2032F |
6.2.5 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Others, 2022-2032F |
6.3 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Hospital Pharmacy, 2022-2032F |
6.3.3 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Retail Pharmacy, 2022-2032F |
6.3.4 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Online Pharmacy, 2022-2032F |
7 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Export to Major Countries |
7.2 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Imports from Major Countries |
8 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Key Performance Indicators |
8.1 Average prescription rate of NSAIDs by healthcare professionals in the UK. |
8.2 Number of clinical trials and research studies on the efficacy and safety of NSAIDs in the UK. |
8.3 Patient satisfaction levels and feedback on the use of NSAIDs for pain management in the UK. |
9 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market - Opportunity Assessment |
9.1 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.2 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Disease Indication, 2022 & 2032F |
9.3 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market - Competitive Landscape |
10.1 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Revenue Share, By Companies, 2025 |
10.2 United Kingdom (UK) Non-steroidal Anti-inflammatory Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here